American Journal of Ophthalmology
Volume 145, Issue 1 , Pages 106-113 , January 2008

Cost Analysis of Glaucoma Medications

,Accepted 28 August 2007.

References 

  1. Traverso CE, Walt JG, Kelly SP, et al. Direct costs of glaucoma and severity of the disease: a multinational long-term study of resource utilization in Europe. Br J Ophthalmol. 2005;89:1245–1249
  2. Lee PP, Walt JG, Doyle JJ, et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol. 2006;124:12–19
  3. IMS Health. http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_3665_77180090,00.htmlAccessed Date: October 12, 2006
  4. Vold SD, Wiggins DA, Jackimiec J. Cost analysis of glaucoma medications. J Glaucoma. 2000;9:150–153
  5. Vold SD, Riggs WL, Jackimiec J. Cost analysis of glaucoma medications: a three-year review. J Glaucoma. 2002;11:354–358
  6. Fiscella RG, Geller JL, Gryz LL, Wilensky J, Viana M. Cost considerations of medical therapy for glaucoma. Am J Ophthalmol. 1999;128:426–433
  7. Fiscella RG, Green A, Patuszynski DH, Wilensky J. Medical therapy cost considerations for glaucoma. Am J Ophthalmol. 2003;136:18–25
  8. Murray L. Red Book. In: Montvale, New Jersey: Thomson PDR; 2006;p. 211–721

PII: S0002-9394(07)00788-X

doi: 10.1016/j.ajo.2007.08.041

American Journal of Ophthalmology
Volume 145, Issue 1 , Pages 106-113 , January 2008